The aging boomer population contributed $8.3 trillion in economic activity to the 2018 US economy, and that number is projected to triple by 2050. The need for advancements in drugs, devices, diagnostics, and digital health for the treatment of age-related conditions is crucial. RESI Longevity is a new partnering conference focused on conditions related to aging, market challenges, and solutions via early-stage companies and their promising tech and products. RESI Longevity brings fundraising startups together with investors in longevity innovation to make deals in order that today’s seniors live longer, healthier lives.
Want to stay connected to active investment mandates in longevity and age-tech? Sign up for Age-Tech Bulletin, a weekly newsletter delivering investment mandates straight to your inbox!
RESI Longevity is committed to facilitating conversations that spark early-stage deals across drugs, devices, diagnostics, and digital health that save lives and change the world through healthcare innovation. To advance the most successful deals, all major players, including both buyers and sellers, are saved a seat at the table.